论文部分内容阅读
前言电痙攣治疗(簡称ECT)自1937年Cerletti及Bini二氏首先应用以来,在精神病临床治疗中获得一定疗效,因其可产生一定并发症;且近年来精神药理学进展,已有被化学疗法取代的趋势,但本治疗仍不失其治疗应用价值,尤其合并肌松弛剂时;減少治疗并发症、縮小禁忌症范围,扩大治疗适应范围。文献温习氯化琥珀酸胆碱(簡称SCC.)为肌松弛剂一种,1949年Bovet发現其肌松弛作用。其药理作用系当靜脉注射后可使神經肌肉終板发生毀极作用阻断传导。
Introduction Electrospasm therapy (referred to as ECT) Cerletti and Bini since 1937, the first application of the clinical treatment of psychosis to obtain a certain effect, because it can produce some complications; and psychopharmacological advances in recent years, has been the chemical Therapy, but the treatment is still the treatment of its application value, especially when combined with muscle relaxants; reduce the treatment of complications, reduce the scope of contraindications, expand the scope of treatment. Literature review Choline chloride succinate (referred to as SCC.) A muscle relaxant, found in 1949 Bovet muscle relaxation. Its pharmacological effects when the intravenous injection can make the neuromuscular end plate devastating effect blocking conduction.